Table 1.
Characteristics of patients with acute myeloid leukemia
| Karyotype abnormalities |
Therapy | Cause of death |
|---|---|---|
| + 8 | DAC | Sepsis after induction therapy |
| Normal | DAC, consolidation, AlloHSCT | GvHD, infection complications |
| Unknown | DAC | Sepsis after induction therapy |
| Unknown | CLAG | Refractoriness on therapy |
| Inv(16) | DAC, consolidation | Alive |
| Complex changes | CLAG | Refractoriness on therapy |
| Normal | DAC, consolidation | Relapse |
| t(8;21) | DAC, consolidation | Alive |
| -Y | DAC, consolidation | Aspergillosis |
| Complex changes | DAC, CLAG-M, consolidation, AlloHSCT | Relapse |
| Normal | DAC, consolidation, AlloHSCT | Relapse |
| Complex changes | DAC, consolidation, AlloHSCT | Relapse |
| Normal | DAC, CLAG-M | Refractoriness on therapy, aspergillosis |
| Normal | DAC, Consolidation, AlloHSCT | Relapse |